Genomic landscape and gene interactions in NPM1 mutation AML. (A) Gene interaction analysis, including all genes with mutations in >3% of the patients and also TP53. (B) Comutated genes by NPM1 mutation type and karyotype. (C) Genomic features of the NPM1 mutation types. (D) Relationship between age, WCC, and NPM1 mutation types.